Experimental Drug May Boost Leukemia Survival, Without Chemo
Idelalisib is being fast-tracked for FDA approval for use in patients with chronic lymphocytic leukemiaContinue Reading
Idelalisib is being fast-tracked for FDA approval for use in patients with chronic lymphocytic leukemiaContinue Reading
Scans showed less response to negative images of habit’s consequencesContinue Reading
But researchers found less expensive treatment was more likely to lead to urinary complicationsContinue Reading
Gap projected to reach nearly 1,500 specialists in a decade, American Society of Clinical Oncology cautionsContinue Reading
Large study followed patients with nonmelanoma skin cancer for 6 yearsContinue Reading
Devices may serve as gateway to tobacco use, study author saysContinue Reading
Study found patients who were more active had fewer hospitalizations from lung conditionContinue Reading
Study adds fodder to the operate vs. ‘watch and wait’ debateContinue Reading
Change factors like exercise while you can, Finnish researchers adviseContinue Reading
Measurements suggest raised risk for later heart attack, stroke, researchers sayContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.